• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Malaysia Pharmaceuticals and Healthcare Report Q4 2011 - Product Image

Malaysia Pharmaceuticals and Healthcare Report Q4 2011

  • Published: September 2011
  • Region: Malaysia
  • 101 Pages
  • Business Monitor International

FEATURED COMPANIES

  • Bumimedic Sdn Bhd
  • GlaxoSmithKline (GSK)
  • Kotra Pharma
  • Multinational Companies
  • Pfizer
  • Prime Pharmaceutical
  • MORE

Business Monitor International's Malaysia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Malaysia's pharmaceuticals and healthcare industry.

BMI View: Malaysia remains a moderately attractive South-East Asian pharmaceutical market. Key positives include economic development and the government’s drive to increase biotechnology investment in the country, supported by epidemiological and demographic factors. However, per-capita expenditure on medicines – much of which is sourced out-of-pocket – will continue to represent a drag on annual growth rates, while also encouraging the use of cheaper generic medicines.

Headline Expenditure Projections
- Pharmaceuticals: MYR4.51bn (US$1.40bn) in 2010 to MYR4.83bn (US$1.61bn) in 2011; +7.1% in local currency and +14.7% in US dollars. Forecast unchanged from Q311.
- Healthcare: MYR36.39bn (US$11.32bn) in 2010 to MYR38.93bn (US$12.98bn) in 2011; +7.0% in local currency and +14.6% in US dollars. Forecast unchanged from Q311.
- READ MORE >

Executive Summary

SWOT Analysis
Malaysia Pharmaceuticals And Healthcare Industry SWOT
Malaysia Political SWOT
Malaysia Economic SWOT
Malaysia Business Environment SWOT

Pharmaceutical Business Environment Ratings

Table: Asia Pacific Pharmaceutical Business Environment Ratings For Q411
Rewards
Risks
Malaysia – Market Summary
Regulatory Regime
Bioequivalence

Pharmaceutical And Medical Advertising
Labelling Requirements
Recent Regulatory Developments
Intellectual Property Regime
Counterfeit Pharmaceuticals
Compulsory Licensing
Free Trade Agreements
Pricing And Reimbursement
Industry Trends And Developments

Epidemiology
Table: 10 Leading Causes Of Death In Ministry of Health Hospitals, 2005

Communicable Diseases
Healthcare Sector
Healthcare Sector Funding
Medical Tourism

Biotechnology And Research
Table: Key Points Of The Malaysian National Biotechnology Policy
Table: The Benefits Of Conducting Biotechnology Research In Malaysia
Recent Biotechnology Developments
Clinical Trials
Recent Developments in the Clinical Trials Industry
Medical Devices
Leading Medical Device Players
Recent Developments In The Medical Devices Industry
Industry Forecast Scenario
Overall Market Forecast
Table: Pharmaceutical Sales Indicators 2007-2015
Key Growth Factors – Industry
Table: Healthcare Expenditure Indicators 2007-2015
Table: Government Healthcare Expenditure Indicators 2007-2015
Table: Private Healthcare Expenditure Indicators 2007-2015
Key Growth Factors – Macroeconomic
Table: Malaysia – Economic Activity
Prescription Drug Market Forecast
Table: Prescription Drug Sales Indicators 2007-2015
Patented Drug Market Forecast
Table: Patented Drug Market Indicators 2007-2015
Generic Drug Market Forecast
Table: Generic Drug Sales Indicators 2007-2015
OTC Medicine Market Forecast
Table: OTC Medicine Sales Indicators 2007-2015
Medical Device Market Forecast
Table: Medical Devices Sales Indicators 2007-2015
Pharmaceutical Trade Forecast
Table: Exports and Imports Indicators 2007-2015
Other Healthcare Data Forecasts

Key Risks To BMI’s Forecast Scenario

Competitive Landscape Analysis
Domestic Pharmaceutical Industry
Foreign Pharmaceutical Industry
Pharmaceutical Demand

Recent Company Activities
Table: Leading Malaysian Pharmaceutical And Healthcare Companies

Halal Medicine
Traditional Medicine
Pharmaceutical Distribution

Company Profiles
Leading Domestic Manufacturers
Pharmaniaga
Prime Pharmaceutical
Bumimedic Sdn Bhd
Hovid
Chemical Company of Malaysia (CCM)
Kotra Pharma
Multinational Companies
GlaxoSmithKline (GSK)
Pfizer
Novartis
Merck & Co
Sanofi-Aventis
Eli Lilly Malaysia
Ranbaxy Malaysia

Country Snapshot: Malaysia Demographic Data
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education And Healthcare
Table: Education, 2000-2003
Table: Vital Statistics, 2005-2030
Glossary

BMI Methodology
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceuticals Business Environment Ratings
Risk/Reward Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources

- Pharmaniaga
- Prime Pharmaceutical
- Bumimedic Sdn Bhd
- Hovid
- Chemical Company of Malaysia (CCM)
- Kotra Pharma
- Multinational Companies
- GlaxoSmithKline (GSK)
- Pfizer
- Novartis
- Merck & Co
- Sanofi-Aventis
- Eli Lilly Malaysia
- Ranbaxy Malaysia

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos